Cellexcel Ltd - Period Ending 2022-08-31

Cellexcel Ltd - Period Ending 2022-08-31


Cellexcel Ltd 13550753 false 2021-08-05 2022-08-31 2022-08-31 The principal activity of the company is to manufacture water resitance bio composite materials to replace fibre glass, plastics and metals. Digita Accounts Production Advanced 6.30.9574.0 true 13550753 2021-08-05 2022-08-31 13550753 2022-08-31 13550753 bus:OrdinaryShareClass1 2022-08-31 13550753 core:CurrentFinancialInstruments 2022-08-31 13550753 core:CurrentFinancialInstruments core:WithinOneYear 2022-08-31 13550753 core:Non-currentFinancialInstruments 2022-08-31 13550753 core:Non-currentFinancialInstruments core:AfterOneYear 2022-08-31 13550753 bus:SmallEntities 2021-08-05 2022-08-31 13550753 bus:AuditExemptWithAccountantsReport 2021-08-05 2022-08-31 13550753 bus:FullAccounts 2021-08-05 2022-08-31 13550753 bus:SmallCompaniesRegimeForAccounts 2021-08-05 2022-08-31 13550753 bus:RegisteredOffice 2021-08-05 2022-08-31 13550753 bus:Director1 2021-08-05 2022-08-31 13550753 bus:Director2 2021-08-05 2022-08-31 13550753 bus:Director3 2021-08-05 2022-08-31 13550753 bus:Director4 2021-08-05 2022-08-31 13550753 bus:Director5 2021-08-05 2022-08-31 13550753 bus:OrdinaryShareClass1 2021-08-05 2022-08-31 13550753 bus:PrivateLimitedCompanyLtd 2021-08-05 2022-08-31 13550753 core:UKTax 2021-08-05 2022-08-31 13550753 countries:England 2021-08-05 2022-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13550753

Cellexcel Ltd

Annual Report and Unaudited Financial Statements

for the Period from 5 August 2021 to 31 August 2022

 

Cellexcel Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

Cellexcel Ltd

Company Information

Directors

Dr Jonathan Carter

Dr Margery Louise Sutherland

Dr Philipp Johannes Tallafuss

Dr Joita Dey

Timothy Denzil Pryce

Registered office

The Enterprise Centre
University of East Anglia
Norwich
NORFOLK
NR4 7TJ

Accountants

Max Accountants Ltd
Ketton Suite
The King Centre
Barleythorpe
Rutland
LE15 7WD

 

Cellexcel Ltd

(Registration number: 13550753)
Balance Sheet as at 31 August 2022

Note

2022
£

Current assets

 

Debtors

5

7,083

Cash at bank and in hand

 

163,838

 

170,921

Creditors: Amounts falling due within one year

6

(5,452)

Total assets less current liabilities

 

165,469

Creditors: Amounts falling due after more than one year

6

(200,000)

Net liabilities

 

(34,531)

Capital and reserves

 

Called up share capital

7

10

Retained earnings

(34,541)

Shareholders' deficit

 

(34,531)

For the financial period ending 31 August 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 10 February 2023 and signed on its behalf by:
 

.........................................
Dr Jonathan Carter
Director

 

Cellexcel Ltd

Notes to the Unaudited Financial Statements for the Period from 5 August 2021 to 31 August 2022

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
The Enterprise Centre
University of East Anglia
Norwich
NORFOLK
NR4 7TJ

These financial statements were authorised for issue by the Board on 10 February 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Cellexcel Ltd

Notes to the Unaudited Financial Statements for the Period from 5 August 2021 to 31 August 2022

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific cirteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic lives.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.
 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 1.

 

Cellexcel Ltd

Notes to the Unaudited Financial Statements for the Period from 5 August 2021 to 31 August 2022

4

Taxation

Tax charged/(credited) in the income statement

5 August 2021 to 31 August 2022
 £

Current taxation

UK corporation tax

(6,961)

Taxation for the year includes a repayable R&D tax credit of £6,961. As at 31 August 2022, the Company had losses of £20,630 available to carry forward against future trading profits for corporation tax purposes
 

5

Debtors

Current

2022
£

Other debtors

7,083

 

Cellexcel Ltd

Notes to the Unaudited Financial Statements for the Period from 5 August 2021 to 31 August 2022

6

Creditors

Creditors: amounts falling due within one year

2022
£

Due within one year

Trade creditors

3,654

Accruals and deferred income

750

Other creditors

1,048

5,452

Creditors: amounts falling due after more than one year

Note

2022
£

Due after one year

 

Loans and borrowings

8

200,000

7

Share capital

Allotted, called up and fully paid shares

 

2022

 

No.

£

Ordinary shares of £0.01 each

1,000

10

     

8

Loans and borrowings

2022
£

Non-current loans and borrowings

Convertible debt

200,000